Goldman Sachs maintained a Neutral rating on Gilead Sciences (NASDAQ: GILD) and raised its price target of $82.00 (from $75.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE